Victrex plc (OTCMKTS:VTXPF) – Analysts at Jefferies Financial Group decreased their FY2021 EPS estimates for Victrex in a research note issued on Tuesday, October 27th. Jefferies Financial Group analyst J. Pominkiewicz now expects that the company will post earnings of $1.07 per share for the year, down from their previous estimate of $1.10. Jefferies Financial Group also issued estimates for Victrex’s FY2022 earnings at $1.34 EPS.
A number of other research analysts have also recently commented on VTXPF. Barclays restated an “underweight” rating on shares of Victrex in a report on Monday, August 24th. CSFB restated an “outperform” rating on shares of Victrex in a report on Wednesday, October 7th. Zacks Investment Research upgraded shares of Victrex from a “sell” rating to a “hold” rating in a report on Wednesday, September 9th. Credit Suisse Group restated an “outperform” rating on shares of Victrex in a report on Wednesday, October 7th. Finally, UBS Group restated a “sell” rating on shares of Victrex in a report on Wednesday, July 8th. Three analysts have rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $35.00.
VTXPF stock opened at $25.60 on Wednesday. The company has a quick ratio of 2.40, a current ratio of 4.40 and a debt-to-equity ratio of 0.01. Victrex has a twelve month low of $21.82 and a twelve month high of $33.55. The stock has a market capitalization of $2.22 billion, a price-to-earnings ratio of 18.82 and a beta of 1.37. The firm’s fifty day simple moving average is $24.96 and its two-hundred day simple moving average is $24.92.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
Featured Article: Reverse Stock Split
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.